Search Results - "H Andris"

Refine Results
  1. 1

    Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction by Stub, Dion, Smith, Karen, Bernard, Stephen, Nehme, Ziad, Stephenson, Michael, Bray, Janet E, Cameron, Peter, Barger, Bill, Ellims, Andris H, Taylor, Andrew J, Meredith, Ian T, Kaye, David M

    Published in Circulation (New York, N.Y.) (16-06-2015)
    “…Oxygen is commonly administered to patients with ST-elevation-myocardial infarction despite previous studies suggesting a possible increase in myocardial…”
    Get full text
    Journal Article
  2. 2

    Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy by Fang, Lu, Ellims, Andris H, Moore, Xiao-lei, White, David A, Taylor, Andrew J, Chin-Dusting, Jaye, Dart, Anthony M

    Published in Journal of translational medicine (24-09-2015)
    “…Circulating microRNAs may represent novel markers for cardiovascular diseases. We evaluated whether circulating miRNAs served as potential biomarkers for…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy by Fang, Lu, Ellims, Andris H, Beale, Anna L, Taylor, Andrew J, Murphy, Andrew, Dart, Anthony M

    Published in American journal of translational research (01-01-2017)
    “…Regional or diffuse fibrosis is an early feature of hypertrophic cardiomyopathy (HCM) and is related to poor prognosis. Previous studies have documented…”
    Get full text
    Journal Article
  5. 5

    Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure by Nguyen, My-Nhan, Su, Yidan, Vizi, Donna, Fang, Lu, Ellims, Andris H., Zhao, Wei-Bo, Kiriazis, Helen, Gao, Xiao-Ming, Sadoshima, Junichi, Taylor, Andrew J., McMullen, Julie R., Dart, Anthony M., Kaye, David M., Du, Xiao-Jun

    Published in Scientific reports (29-05-2018)
    “…Galectin-3 is a biomarker of heart disease. However, it remains unknown whether increase in galectin-3 levels is dependent on aetiology or disease-associated…”
    Get full text
    Journal Article
  6. 6

    Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis by Iles, Leah M, Ellims, Andris H, Llewellyn, Huw, Hare, James L, Kaye, David M, McLean, Catriona A, Taylor, Andrew J

    “…Myocardial fibrosis is fundamental in the pathogenesis of heart failure. Late gadolinium enhancement (LGE) with cardiac magnetic resonance (CMR) imaging is…”
    Get full text
    Journal Article
  7. 7

    Diffuse Ventricular Fibrosis in Atrial Fibrillation: Noninvasive Evaluation and Relationships With Aging and Systolic Dysfunction by LING, Liang-Han, KISTLER, Peter M, ELLIMS, Andris H, ILES, Leah M, LEE, Geraldine, HUGHES, Gerard L, KALMAN, Jonathan M, KAYE, David M, TAYLOR, Andrew J

    “…The purpose of this study was to evaluate diffuse myocardial fibrosis of the left ventricle (LV) in patients with atrial fibrillation (AF). Diffuse myocardial…”
    Get full text
    Journal Article
  8. 8

    Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction by Ellims, Andris H, Iles, Leah M, Ling, Liang-han, Hare, James L, Kaye, David M, Taylor, Andrew J

    “…The presence of myocardial fibrosis is associated with worse clinical outcomes in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance (CMR)…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction by Nehme, Ziad, Stub, Dion, Bernard, Stephen, Stephenson, Michael, Bray, Janet E, Cameron, Peter, Meredith, Ian T, Barger, Bill, Ellims, Andris H, Taylor, Andrew J, Kaye, David M, Smith, Karen

    Published in Heart (British Cardiac Society) (01-03-2016)
    “…Supplemental oxygen therapy may increase myocardial injury following ST-elevation myocardial infarction (STEMI). In this study, we aimed to evaluate the effect…”
    Get more information
    Journal Article
  12. 12

    Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy by Ellims, Andris H, Taylor, Andrew J, Mariani, Justin A, Ling, Liang-Han, Iles, Leah M, Maeder, Micha T, Kaye, David M

    Published in Circulation. Heart failure (01-03-2014)
    “…In hypertrophic cardiomyopathy (HCM), accumulation of myocardial collagen may play a central role in the pathogenesis of diastolic dysfunction and arrhythmia…”
    Get full text
    Journal Article
  13. 13

    Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion by Chan, William, Duffy, Stephen J, White, David A, Gao, Xiao-Ming, Du, Xiao-Jun, Ellims, Andris H, Dart, Anthony M, Taylor, Andrew J

    Published in JACC. Cardiovascular imaging (01-09-2012)
    “…This prospective study aimed to assess regional and temporal patterns of extracellular matrix (ECM) changes post-myocardial infarction (MI). A fundamental…”
    Get full text
    Journal Article
  14. 14

    Diffuse Ventricular Fibrosis Is a Late Outcome of Tachycardia-Mediated Cardiomyopathy After Successful Ablation by Ling, Liang-han, Kalman, Jonathan M., Ellims, Andris H., Iles, Leah M., Medi, Caroline, Sherratt, Craig, Kaye, David M., Hare, James L., Kistler, Peter M., Taylor, Andrew J.

    “…BACKGROUND—Successful arrhythmia ablation normalizes ejection fraction (EF) in tachycardia-mediated cardiomyopathy, but recurrent heart failure and late sudden…”
    Get full text
    Journal Article
  15. 15

    The Role of Left Atrial Imaging in the Management of Atrial Fibrillation by Walters, Tomos E, Ellims, Andris H, Kalman, Jonathan M

    Published in Progress in cardiovascular diseases (01-09-2015)
    “…Abstract Atrial fibrillation (AF) is the most commonly encountered sustained cardiac rhythm disorder, is an independent risk factor for stroke, heart failure…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation-Myocardial Infarction by CHAN, William, TAYLOR, Andrew J, DART, Anthony M, DUFFY, Stephen J, ELLIMS, Andris H, LEFKOVITS, Lisa, WONG, Chiew, KINGWELL, Bronwyn A, NATOLI, Alaina, CROFT, Kevin D, MORI, Trevor, KAYE, David M

    Published in Circulation. Cardiovascular interventions (01-04-2012)
    “…Experimental studies suggest that deferoxamine (DFO) limits the generation of reactive oxygen species by chelating redox-active iron and thereby may reduce…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T by Costello, Benedict T., Springer, Fabian, Hare, James L., Gerche, Andre La, Iles, Leah, Ellims, Andris H., Schmitt, Benjamin, Taylor, Andrew J.

    “…Cardiac Magnetic Resonance derived T1 mapping parameters are a non-invasive method of estimating diffuse myocardial fibrosis. This study aims to to determine…”
    Get full text
    Journal Article